Sebia Serum Free Light Chain Assay
Sebia’s serum free light chain (sFLC) assay is an FDA-cleared test for diagnosing and monitoring multiple myeloma and AL amyloidosis. It delivers precise quantifications of free kappa and lambda light chains with high specificity, broad range, and flexible automation—empowering confident, efficient clinical decisions.
Long Description
Sebia’s Serum Free Light Chain (sFLC) assay is an FDA-cleared test for quantifying free kappa and lambda light chains in serum to aid in the diagnosis and monitoring of multiple myeloma and AL amyloidosis. Designed for both manual and automated workflows, it offers labs flexible integration, high reproducibility, and a broad dynamic range—reducing repeat testing and boosting efficiency. With sensitivity equivalent to leading methods and superior specificity, it helps reduce false positives and supports confident clinical decisions. Backed by Sebia’s expert training and technical service, our sFLC assay is a cost-effective, reliable, and trusted solution for routine and specialty free light chain testing.
High Resolution Image
Small Image
Large Image
Category Product Showcase